Prucalopride is a dihydrobenzofurancarboxamide derivative from the benzofurane family that selectively stimulates 5-HT4 receptors and thus, it presents enterokinetic properties. The high selectivity of prucalopride allowed further development as it prevented the cardiac adverse reactions observed due to non-target effects of precedent therapies. It is grouped under the following drug class(es): Prokinetic agents. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Resotran and Prudac. Its PubChem CID is 3052762.
Prucalopride
| CAS No | 179474-81-8 |
|---|---|
| Molecular Formula | C18H26ClN3O3 |
| Molecular Weight | 367.9 g/mol |
| Synonyms | 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Prucalopride is a dihydrobenzofurancarboxamide derivative from the benzofurane family that selectively stimulates 5-HT4 receptors and thus, it presents enterokinetic properties.
The listed CAS number is 179474-81-8.
The listed molecular formula is C18H26ClN3O3.
The listed molecular weight is 367.9 g/mol.
4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide.
The source lists Resotran and Prudac.